《亞洲股市》中港股市下滑1.7%-2.3% 日韓股續跌0.7% 惟印尼及星馬泰菲股逆升
美股期貨全面反覆偏軟,道指期貨報34,777,反覆續跌41點或0.1%。亞太區股市今天個別發展。內地官媒《人民日報》促請加快完善互聯診療讓人們在線上線下都能安心就醫購藥,加上內地通過個人信息保護法,違法應用程序將被責令暫停或終止服務,中港股市在相關板塊遭拋售等拖累急挫,滬指及深成半日收3,408及14,171,分別續跌近1.7%及回吐2.2%;阿裏健康(00241.HK)及藥明生物(02269.HK)急挫13%及10%,屢尋底阿裏巴巴(09988.HK)、友邦(01299.HK)、港交所(00388.HK)、舜宇(02382.HK)、比亞迪(01211.HK)、吉利(00175.HK)、安踏(02020.HK)、金沙(01928.HK)、銀娛(00027.HK)、海底撈(06862.HK)、美團(03690.HK)及碧桂園服務(06098.HK)挫2%-7%,拖累恆指跌破7月27日盤中所創低位24,748,最低見24,581,創逾八個月低,半日收24,739,續挫576點或2.3%。
越南迴吐1.3%報1,356。印度孟買指數假後重開續跌0.6%,報55,277。日經報27,089,反覆續跌0.7%。韓股繼昨天急挫1.9%後,今早低見3,060,現報3,076,續跌0.7%。新西蘭50指數高見12,976後倒跌0.1%,報12,942。
相反,新加坡海峽時報指數扭轉昨天跌1.4%勢,回升0.8%報3,110;吉隆坡綜合指數回升0.3%報1,519。菲股五連升,最低見6,707,現報6,731,反覆續升0.2%;泰股回升0.4%報1,550。臺灣加權指數繼昨天低收急挫2.7%創近三個月低後,今早低見16,248獲承接,掉頭高見16,507,現報16,395,倒升0.1%。印尼繼昨天挫逾2%後,今早低見5,938,現報6,002,倒升0.2%。澳洲200扭四連吐,報7,472,反覆回升0.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.